MedPath

The investigation of blood concentration of magnesium after an oral intake

Not Applicable
Conditions
not applicable
Registration Number
JPRN-UMIN000032590
Lead Sponsor
Tokushima University Hospital Anesthesiology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Male
Target Recruitment
10
Inclusion Criteria

Not provided

Exclusion Criteria

ASA PS2-6 female under 20 years old over 65 years old

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
blood concentration of ionized magnesium (before intaking magnesium,every 1 hour afte-r intaking magnesium until 6 hours)
Secondary Outcome Measures
NameTimeMethod
blood concentration of ionized calcium, so-dium, potassium, and chloride (before intaking magnesium,every 1 hour af-ter intaking magnesium until 6 hours) oxidative stress antioxidative activity
© Copyright 2025. All Rights Reserved by MedPath